The Canadian doctor who helped invent Ozempic – Macleans.ca
Decades ago, Toronto researcher Daniel Drucker co-discovered a hormone that paved the way for today’s most-talked-about drug. Does he get the hype? Yes and no.
Decades ago, Toronto researcher Daniel Drucker co-discovered a hormone that paved the way for today’s most-talked-about drug. Does he get the hype? Yes and no.
An abstract is unavailable.
f eGFR laboratory data and case report forms had not been completed. This resulted in a small number of kidney composite events and a nominal…
“CMS Seeks Input on Medicare Advantage Data, Implements Changes to Data Access and Use” published on 08 Apr 2024 by American Society of Nephrology.
One platform for interactive learning, engagement and collaborative knowledge
se renal lymphatic endothelial cells in quiescent and cisplatin-injured kidneys. Lymphatic endothelial cell gene expression changes were confirmed in ischemia–reperfusion injury and in cultured lymphatic…
Advocates for improved equity in kidney transplant in the US have recently focused efforts on initiatives to increase referral for transplant evaluation. However, because donor…
RPA offers governance volunteer opportunit ies to get involved with RPA. Committees serve as the thought leadership workforce of RPA and are a great opportunity…
Less is more. Illustrations of the validity of this mantra in life and clinical medicine are not hard to find. Examples abound in the realm…
The FDA has granted Outset Medical Inc. 510(k) clearance of TabloCart with Prefiltration, an optional accessory for the Tablo Hemodialysis System, according to a press…
Serving the Underserved The following article is the fourth of a five-issue series focused on caring for patients in underserved populations. Inspired by several sessions…